Citations (78)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Anita Yadav, Tannu Kharewal, Neelam Verma, Nimisha Tehri, Anjum Gahlaut & Vikas Hooda. (2023) Electrochemical biosensors for the quantification of streptomycin in food systems: an overview. International Journal of Environmental Analytical Chemistry 103:17, pages 5835-5850.
Read now
Read now
A. Lip, D. Karsanji, J. Grossman & S.K. Field. (2022) Successful hematopoietic stem cell transplantation for acute myelomonocytic leukemia in a patient with active pulmonary tuberculosis. Canadian Journal of Respiratory, Critical Care, and Sleep Medicine 6:4, pages 275-278.
Read now
Read now
Ashlee D. Brunaugh, Shivam Sharma & Hugh Smyth. (2021) Inhaled fixed-dose combination powders for the treatment of respiratory infections. Expert Opinion on Drug Delivery 18:8, pages 1101-1115.
Read now
Read now
Michael Lauzardo & Charles A. Peloquin. (2016) Tuberculosis therapy for 2016 and beyond. Expert Opinion on Pharmacotherapy 17:14, pages 1859-1872.
Read now
Read now
Michael Lauzardo & Charles A. Peloquin. (2012) Antituberculosis therapy for 2012 and beyond. Expert Opinion on Pharmacotherapy 13:4, pages 511-526.
Read now
Read now
Herbert A Kirst. (2012) Recent derivatives from smaller classes of fermentation-derived antibacterials. Expert Opinion on Therapeutic Patents 22:1, pages 15-35.
Read now
Read now
Cheuk-Ming Tam, Wing-Wai Yew & Kwok-Yung Yuen. (2009) Treatment of multidrug-resistant and extensively drug-resistant tuberculosis: current status and future prospects. Expert Review of Clinical Pharmacology 2:4, pages 405-421.
Read now
Read now
Articles from other publishers (71)
Amira G. Zawal, Marwa M. Abdel‐Aziz, Abdalla A. El‐Shanawani, Lobna M. Abdel‐Aziz, Mohamed Taha, Claire Simons & Samar S. Elbaramawi. (2023)
Targeting
Mycobacterium tuberculosis
: Synthesis, in vitro and in silico evaluation of novel
N
1
‐(benzo[
d
]oxazol‐2‐yl)‐
N
4
‐arylidine compounds
. Archiv der Pharmazie 356:8.
Crossref
Crossref
Archna Yadav, C.P. Kaushik & Mukesh Kumar. (2023) Hydrazones tethered disubstituted 1,2,3-triazoles: Design, synthesis, antitubercular and antimicrobial evaluation. Journal of Molecular Structure 1283, pages 135163.
Crossref
Crossref
Khushboo Borah Slater, Daniel Kim, Pooja Chand, Ye Xu, Hanif Shaikh & Vaishali Undale. (2023) A Current Perspective on the Potential of Nanomedicine for Anti-Tuberculosis Therapy. Tropical Medicine and Infectious Disease 8:2, pages 100.
Crossref
Crossref
Parul Singh & Aishwarya Govindaswamy. 2023. Diagnosis of Mycobacterium. Diagnosis of Mycobacterium
103
124
.
Thomas Manning, Jenu Thomas-Richardson, Courtney Johnson, Krupesh Patel, Yatri Thaker, Govind Thomas-Richardson, Dennis Philips & Greg Wylie. 2023. Tuberculosis. Tuberculosis
305
320
.
Ashlan J. Kunz Coyne, Anthony M. Casapao & Eric F. Egelund. 2023. Tuberculosis. Tuberculosis
257
275
.
Wenjing Zhang. (2022) Deterministic and stochastic in-host tuberculosis models for bacterium-directed and host-directed therapy combination. Mathematical Medicine and Biology: A Journal of the IMA 39:2, pages 126-155.
Crossref
Crossref
Pingping Jia, Yi Zhang, Jian Xu, Mei Zhu, Shize Peng, Yongxin Zhang, Jianyuan Zhao, Xiaoyu Li, Kaixia Mi, Dan Yan, Yucheng Wang, Liyan Yu, Yu Lu, Hanping Shi & Shan Cen. (2022) IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection. The Journal of Infectious Diseases 225:4, pages 608-616.
Crossref
Crossref
Tanmaya Talukdar, Vidushi Rathi & Pranav Ish. (2022) Geriatric tuberculosis in India-challenges and solutions. Indian Journal of Tuberculosis 69, pages S209-S212.
Crossref
Crossref
Sara Occhineri, Tommaso Matucci, Laura Rindi, Giusy Tiseo, Marco Falcone, Niccolò Riccardi & Giorgio Besozzi. (2022) Pretomanid for tuberculosis treatment: an update for clinical purposes. Current Research in Pharmacology and Drug Discovery 3, pages 100128.
Crossref
Crossref
Zhiguo Wang & Baofeng YangZhiguo Wang & Baofeng Yang. 2022. Polypharmacology. Polypharmacology
271
299
.
Prakash Khadka, Shubhra Sinha, Ian G. Tucker, Jack Dummer, Philip C. Hill, Rajesh Katare & Shyamal C. Das. (2021) Studies on the safety and the tissue distribution of inhaled high-dose amorphous and crystalline rifampicin in a rat model. International Journal of Pharmaceutics 597, pages 120345.
Crossref
Crossref
Susanna Edith Medellin-Garibay, Ana Patricia Huerta-García, Ana Socorro Rodríguez-Báez, Martín Magaña-Aquino, Arturo Ortiz-Álvarez, Diana Patricia Portales-Pérez, Rosa del Carmen Milán-Segovia & Silvia Romano-Moreno. (2020) A population approach of rifampicin pharmacogenetics and pharmacokinetics in Mexican patients with tuberculosis. Tuberculosis 124, pages 101982.
Crossref
Crossref
John Fors, Natasha Strydom, William S. Fox, Ron J. Keizer & Radojka M. Savic. (2020) Mathematical model and tool to explore shorter multi-drug therapy options for active pulmonary tuberculosis. PLOS Computational Biology 16:8, pages e1008107.
Crossref
Crossref
Charles L Daley, Jonathan M Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J WallaceJrJr, Claire Andrejak, Erik C Böttger, Jan Brozek, David E Griffith, Lorenzo Guglielmetti, Gwen A Huitt, Shandra L Knight, Philip Leitman, Theodore K Marras, Kenneth N Olivier, Miguel Santin, Jason E Stout, Enrico Tortoli, Jakko van Ingen, Dirk Wagner & Kevin L Winthrop. (2020) Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clinical Infectious Diseases 71:4, pages e1-e36.
Crossref
Crossref
Charles L. Daley, Jonathan M. Iaccarino, Christoph Lange, Emmanuelle Cambau, Richard J. WallaceJrJr, Claire Andrejak, Erik C. Böttger, Jan Brozek, David E. Griffith, Lorenzo Guglielmetti, Gwen A. Huitt, Shandra L. Knight, Philip Leitman, Theodore K. Marras, Kenneth N. Olivier, Miguel Santin, Jason E. Stout, Enrico Tortoli, Jakko van Ingen, Dirk Wagner & Kevin L. Winthrop. (2020) Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. European Respiratory Journal 56:1, pages 2000535.
Crossref
Crossref
Ryan F Amidon, Christ Ordookhanian, Talia Vartanian & Paul Kaloostian. (2020) A Rare Form of Pott’s Disease With Multifaceted Pathological Complications. Cureus.
Crossref
Crossref
Adel Abouhmad, Ahmed H. Korany, Carl Grey, Tarek Dishisha & Rajni Hatti-Kaul. (2020) Exploring the Enzymatic and Antibacterial Activities of Novel Mycobacteriophage Lysin B Enzymes. International Journal of Molecular Sciences 21:9, pages 3176.
Crossref
Crossref
Motshabi Alinah Sibeko, Victor Chike Agbakoba, Jethro Nkomo & Shanganyane Percy Hlangothi. 2020. Antibiotic Materials in Healthcare. Antibiotic Materials in Healthcare
249
259
.
Moises A. Huaman & Timothy R. Sterling. (2019) Treatment of Latent Tuberculosis Infection—An Update. Clinics in Chest Medicine 40:4, pages 839-848.
Crossref
Crossref
S.K. Katiyar & Sandeep Katiyar. (2019) Protocol for the management of newly diagnosed cases of tuberculosis. Indian Journal of Tuberculosis 66:4, pages 507-515.
Crossref
Crossref
Bhamini Rangnekar, Mohammad A.M. Momin, Basanth Babu Eedara, Shubhra Sinha & Shyamal C. Das. (2019) Bedaquiline containing triple combination powder for inhalation to treat drug-resistant tuberculosis. International Journal of Pharmaceutics 570, pages 118689.
Crossref
Crossref
Xin Deng, Zhenjie Liu, Xiaoyang Li, Yang Zhou & Zhengqing Hu. (2019) Generation of new hair cells by DNA methyltransferase (Dnmt) inhibitor 5-azacytidine in a chemically-deafened mouse model. Scientific Reports 9:1.
Crossref
Crossref
Alice K. Pau, Safia Kuriakose, Kelly E. Dooley & Gary Maartens. 2019. HIV and Tuberculosis. HIV and Tuberculosis
181
202
.
Daniela Cirillo, Emanuele Borroni, Irene Festoso, Diego Monti, Sergio Romeo, Dominique Mazier & Luisella Verotta. (2018) Synthesis and antimycobacterial activity of (+)-usnic acid conjugates. Archiv der Pharmazie 351:12, pages 1800177.
Crossref
Crossref
Richard S. Garfein, Lin Liu, Jazmine Cuevas-Mota, Kelly Collins, Fatima Muñoz, Donald G. Catanzaro, Kathleen Moser, Julie Higashi, Teeb Al-Samarrai, Paula Kriner, Julie Vaishampayan, Javier Cepeda, Michelle A. Bulterys, Natasha K. Martin, Phillip Rios & Fredric Raab. (2018) Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA. Emerging Infectious Diseases 24:10, pages 1806-1815.
Crossref
Crossref
K E Stott, H Pertinez, M G G Sturkenboom, M J Boeree, R Aarnoutse, G Ramachandran, A Requena-Méndez, C Peloquin, C F N Koegelenberg, J W C Alffenaar, R Ruslami, A Tostmann, S Swaminathan, H McIlleron & G Davies. (2018) Pharmacokinetics of rifampicin in adult TB patients and healthy volunteers: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy 73:9, pages 2305-2313.
Crossref
Crossref
Basanth Babu Eedara, Bhamini Rangnekar, Shubhra Sinha, Colin Doyle, Alex Cavallaro & Shyamal C. Das. (2018) Development and characterization of high payload combination dry powders of anti-tubercular drugs for treating pulmonary tuberculosis. European Journal of Pharmaceutical Sciences 118, pages 216-226.
Crossref
Crossref
Mostafa M. Ghorab, Mohamed S. A. El-Gaby, Aiten M. Soliman, Mansour S. Alsaid, Marwa M. Abdel-Aziz & Mahmoud M. Elaasser. (2017) Synthesis, docking study and biological evaluation of some new thiourea derivatives bearing benzenesulfonamide moiety. Chemistry Central Journal 11:1.
Crossref
Crossref
Yuhui Xu, Jianan Wu, Sha Liao & Zhaogang Sun. (2017) Treating tuberculosis with high doses of anti-TB drugs: mechanisms and outcomes. Annals of Clinical Microbiology and Antimicrobials 16:1.
Crossref
Crossref
Mohammed Hussen Bule, Faheem Maqbool, Ishtiaq Ahmed, Kuldeep Dhama & Hafiz Muhammad Nasir Iqbal. (2017) Advances in the Treatment Options Towards Drug-Resistant Tuberculosis. International Journal of Pharmacology 13:7, pages 746-761.
Crossref
Crossref
Manitosh Pandey, Alok Kumar Singh, Ritesh Thakare, Sakshi Talwar, Pratiksha Karaulia, Arunava Dasgupta, Sidharth Chopra & Amit Kumar Pandey. (2017) Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity. Scientific Reports 7:1.
Crossref
Crossref
C. A. Peloquin, G. E. Velásquez, L. Lecca, R. I. Calderón, J. Coit, M. Milstein, E. Osso, J. Jimenez, K. Tintaya, E. Sanchez Garavito, D. Vargas Vasquez, C. D. Mitnick & G. Davies. (2017) Pharmacokinetic Evidence from the HIRIF Trial To Support Increased Doses of Rifampin for Tuberculosis. Antimicrobial Agents and Chemotherapy 61:8.
Crossref
Crossref
Lucila Garcia-Contreras, Danielle J. Padilla-Carlin, Jean Sung, Jarod VerBerkmoes, Pavan Muttil, Katharina Elbert, Charles Peloquin, David Edwards & Anthony Hickey. (2017) Pharmacokinetics of Ethionamide Delivered in Spray-Dried Microparticles to the Lungs of Guinea Pigs. Journal of Pharmaceutical Sciences 106:1, pages 331-337.
Crossref
Crossref
Meredith Milstein, Leonid Lecca, Charles Peloquin, Denis Mitchison, Kwonjune Seung, Marcello Pagano, David Coleman, Elna Osso, Julia Coit, Dante Elmo Vargas Vasquez, Epifanio Sanchez Garavito, Roger Calderon, Carmen Contreras, Geraint Davies & Carole D. Mitnick. (2016) Evaluation of high-dose rifampin in patients with new, smear-positive tuberculosis (HIRIF): study protocol for a randomized controlled trial. BMC Infectious Diseases 16:1.
Crossref
Crossref
Vanessa Albertina Agertt, Pauline Cordenonsi Bonez, Caren Rigon Mizdal, Grazielle Guidolin Rossi, Vanessa da Costa Flores & Marli Matiko Anraku de Campos. (2016) In vitro antimicrobial efficacy of a fixed-dose combination of RHZE against M. tuberculosis. Brazilian Journal of Pharmaceutical Sciences 52:3, pages 575-580.
Crossref
Crossref
Hyun Woo Lee, Jung Kyu Lee, Eunyoung Kim, Jae-Joon Yim & Chang-Hoon Lee. (2016) The Effectiveness and Safety of Fluoroquinolone-Containing Regimen as a First-Line Treatment for Drug-Sensitive Pulmonary Tuberculosis: A Systematic Review and Meta-Analysis. PLOS ONE 11:7, pages e0159827.
Crossref
Crossref
David M. Rothstein. (2016) Rifamycins, Alone and in Combination. Cold Spring Harbor Perspectives in Medicine 6:7, pages a027011.
Crossref
Crossref
Aline B. Barth, Eric F. Egelund & Charles A. Peloquin. 2016. Antibiotic Pharmacodynamics. Antibiotic Pharmacodynamics
385
414
.
S.A. Grim, J.E. Layden, P. Roth, S. Gallitano, W. Adams & N.M. Clark. (2015) Latent tuberculosis in kidney and liver transplant patients: a review of treatment practices and outcomes. Transplant Infectious Disease 17:5, pages 768-777.
Crossref
Crossref
EF Egelund, A Alsultan & CA Peloquin. (2015) Optimizing the clinical pharmacology of tuberculosis medications. Clinical Pharmacology & Therapeutics 98:4, pages 387-393.
Crossref
Crossref
Vincent P. DeMarco, Alvaro A. Ordonez, Mariah Klunk, Brendan Prideaux, Hui Wang, Zhang Zhuo, Peter J. Tonge, Robert F. Dannals, Daniel P. Holt, Carlton K. K. Lee, Edward A. Weinstein, Véronique Dartois, Kelly E. Dooley & Sanjay K. Jain. (2015)
Determination of [
11
C]Rifampin Pharmacokinetics within Mycobacterium tuberculosis-Infected Mice by Using Dynamic Positron Emission Tomography Bioimaging
. Antimicrobial Agents and Chemotherapy 59:9, pages 5768-5774.
Crossref
Crossref
Wagdy Eldehna, Mohamed Fares, Marwa Abdel-Aziz & Hatem Abdel-Aziz. (2015) Design, Synthesis and Antitubercular Activity of Certain Nicotinic Acid Hydrazides. Molecules 20:5, pages 8800-8815.
Crossref
Crossref
Gail L. Woods, Shou-Yean Grace Lin & Edward P. Desmond. 2015.
Manual of
Clinical Microbiology
.
Manual of
Clinical Microbiology
1356
1378
.
Susanna E Medellín-Garibay, Rosa del Carmen Milán-Segovia, Martín Magaña-Aquino, Diana Patricia Portales-Pérez & Silvia Romano-Moreno. (2014) Pharmacokinetics of rifampicin in Mexican patients with tuberculosis and healthy volunteers. Journal of Pharmacy and Pharmacology 66:10, pages 1421-1428.
Crossref
Crossref
Navdeep Grover, Elena E. Paskaleva, Krunal K. Mehta, Jonathan S. Dordick & Ravi S. Kane. (2014) Growth inhibition of Mycobacterium smegmatis by mycobacteriophage-derived enzymes. Enzyme and Microbial Technology 63, pages 1-6.
Crossref
Crossref
B. M. Knoll. (2014) Update on Nontuberculous Mycobacterial Infections in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Current Infectious Disease Reports 16:9.
Crossref
Crossref
John Gar Yan Chan, Anneliese S. Tyne, Angel Pang, Hak-Kim Chan, Paul M. Young, Warwick J. Britton, Colin C. Duke & Daniela Traini. (2013) A Rifapentine-Containing Inhaled Triple Antibiotic Formulation for Rapid Treatment of Tubercular Infection. Pharmaceutical Research 31:5, pages 1239-1253.
Crossref
Crossref
Anthony J. Garcia-Prats, Penelope C. Rose, Anneke C. Hesseling & H. Simon Schaaf. (2014) Linezolid for the treatment of drug-resistant tuberculosis in children: A review and recommendations. Tuberculosis 94:2, pages 93-104.
Crossref
Crossref
Stéphanie Vandekerckhove, Tom Desmet, Hai Giang Tran, Carmen de Kock, Peter J. Smith, Kelly Chibale & Matthias D’hooghe. (2014) Synthesis of halogenated 4-quinolones and evaluation of their antiplasmodial activity. Bioorganic & Medicinal Chemistry Letters 24:4, pages 1214-1217.
Crossref
Crossref
C. Padmapriyadarsini & M.S. Jawahar. 2014. A worldwide yearly survey of new data in adverse drug reactions. A worldwide yearly survey of new data in adverse drug reactions
445
456
.
Charles Peloquin. 2014. Applied Pharmacometrics. Applied Pharmacometrics
325
348
.
Pravin Jaiprakash Gupta. 2014. Anal Fistula. Anal Fistula
159
169
.
J. Ho, P. Jelfs & V. Sintchencko. (2013) Phenotypically occult multidrug-resistant Mycobacterium tuberculosis: dilemmas in diagnosis and treatment. Journal of Antimicrobial Chemotherapy 68:12, pages 2915-2920.
Crossref
Crossref
Ethan Rubinstein & Yoav Keynan. (2013) Quinolones for mycobacterial infections. International Journal of Antimicrobial Agents 42:1, pages 1-4.
Crossref
Crossref
Vanessa Albertina Agertt, Lenice Lorenço Marques, Pauline Cordenonsi Bonez, Tanise Vendruscolo Dalmolin, Gelson Noe Manzoni de Oliveira & Marli Matiko Anraku de Campos. (2013) Evaluation of antimycobacterial activity of a sulphonamide derivative. Tuberculosis 93:3, pages 318-321.
Crossref
Crossref
Eric L. Nuermberger, Ian M. Rosenthal, Rokeya Tasneen, Charles A. Peloquin, Khisimuzi E. Mdluli, Petros C. Karakousis & Jacques H. Grosset. (2013) Reply to “Contradictory Results with High-Dosage Rifamycin in Mice and Humans”. Antimicrobial Agents and Chemotherapy 57:2, pages 1104-1105.
Crossref
Crossref
John Gar Yan Chan, Hak-Kim Chan, Clive A. Prestidge, John A. Denman, Paul M. Young & Daniela Traini. (2013) A novel dry powder inhalable formulation incorporating three first-line anti-tubercular antibiotics. European Journal of Pharmaceutics and Biopharmaceutics 83:2, pages 285-292.
Crossref
Crossref
Stephen K. Field, Dina Fisher, Julie M. Jarand & Robert L. Cowie. (2012) New treatment options for multidrug-resistant tuberculosis. Therapeutic Advances in Respiratory Disease 6:5, pages 255-268.
Crossref
Crossref
Rabia Ahmed, Ryan Cooper, Michelle Foisy, Evelina Der & Dennis Kunimoto. (2012) Factors Associated with Reduced Antituberculous Serum Drug Concentrations in Patients with HIV-TB Coinfection. Journal of the International Association of Physicians in AIDS Care 11:5, pages 273-276.
Crossref
Crossref
Jakko van Ingen, Eric F. Egelund, Adrah Levin, Sarah E. Totten, Martin J. Boeree, Johan W. Mouton, Rob E. Aarnoutse, Leonid B. Heifets, Charles A. Peloquin & Charles L. Daley. (2012)
The Pharmacokinetics and Pharmacodynamics of Pulmonary
Mycobacterium avium
Complex Disease Treatment
. American Journal of Respiratory and Critical Care Medicine 186:6, pages 559-565.
Crossref
Crossref
Garth L. Abrahams, Anuradha Kumar, Suzana Savvi, Alvin W. Hung, Shijun Wen, Chris Abell, Clifton E. BarryIIIIII, David R. Sherman, Helena I.M. Boshoff & Valerie Mizrahi. (2012) Pathway-Selective Sensitization of Mycobacterium tuberculosis for Target-Based Whole-Cell Screening. Chemistry & Biology 19:7, pages 844-854.
Crossref
Crossref
Xavier Carette, Nicolas Blondiaux, Eve Willery, Sylviane Hoos, Nathalie Lecat-Guillet, Zoé Lens, Alexandre Wohlkönig, René Wintjens, Sameh H. Soror, Frédéric Frénois, Bertrand Dirié, Vincent Villeret, Patrick England, Guy Lippens, Benoit Deprez, Camille Locht, Nicolas Willand & Alain R. Baulard. (2012) Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligands. Nucleic Acids Research 40:7, pages 3018-3030.
Crossref
Crossref
Marion Flipo, Matthieu Desroses, Nathalie Lecat-Guillet, Baptiste Villemagne, Nicolas Blondiaux, Florence Leroux, Catherine Piveteau, Vanessa Mathys, Marie-Pierre Flament, Juergen Siepmann, Vincent Villeret, Alexandre Wohlkönig, René Wintjens, Sameh H. Soror, Thierry Christophe, Hee Kyoung Jeon, Camille Locht, Priscille Brodin, Benoit Déprez, Alain R. Baulard & Nicolas Willand. (2011) Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors. Journal of Medicinal Chemistry 55:1, pages 68-83.
Crossref
Crossref
Emmanuel Chigutsa, Marianne E. Visser, Elizabeth C. Swart, Paolo Denti, Sudeep Pushpakom, Deirdre Egan, Nicholas H. G. Holford, Peter J. Smith, Gary Maartens, Andrew Owen & Helen McIlleron. (2011)
The
SLCO1B1
rs4149032 Polymorphism Is Highly Prevalent in South Africans and Is Associated with Reduced Rifampin Concentrations: Dosing Implications
. Antimicrobial Agents and Chemotherapy 55:9, pages 4122-4127.
Crossref
Crossref
G. Lui, N. Lee, S.W. Cheung, J.S.Y. Lam, B.C.K. Wong, K.W. Choi, K.T. Wong, R.Y.K. Wong, C.S. Cockram, D.S.C. Hui & R.C.Y. Chan. (2011) Interferon gamma release assay for differentiating tuberculosis among pneumonia cases in acute healthcare setting. Journal of Infection 62:6, pages 440-447.
Crossref
Crossref
Gail L. Woods, Shou-Yean Grace Lin & Edward P. Desmond. 2011. Manual of Clinical Microbiology. Manual of Clinical Microbiology
1215
1238
.
ROSA CREMADES, JUAN CARLOS RODRÍGUEZ, EDUARDO GARCIA-PACHÓN, ANTONIO GALIANA, MONTSERRAT RUIZ-GARCÍA, PILAR LÓPEZ & GLORIA ROYO. (2011) Interaction between linezolid and Mycobacterium tuberculosis in an experimental in vitro model. APMIS 119:4-5, pages 304-308.
Crossref
Crossref
J. Perriot, É. Chambonnet & A. Eschalier. (2011) Les effets indésirables des antituberculeux ; prise en charge. Revue des Maladies Respiratoires 28:4, pages 542-555.
Crossref
Crossref
Vladimir Frecer, Pierfausto Seneci & Stanislav Miertus. (2010) Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Journal of Computer-Aided Molecular Design 25:1, pages 31-49.
Crossref
Crossref
W. A. Hanekom, S. D. Lawn, K. Dheda & A. Whitelaw. (2010) Tuberculosis research update. Tropical Medicine & International Health 15:8, pages 981-989.
Crossref
Crossref